Bioventus (BVS) Inventory (2020 - 2026)
Bioventus filings provide 6 years of Inventory readings, the most recent being $82.2 million for Q4 2025.
- On a quarterly basis, Inventory fell 11.07% to $82.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $82.2 million, a 11.07% decrease, with the full-year FY2025 number at $82.2 million, down 11.07% from a year prior.
- Inventory hit $82.2 million in Q4 2025 for Bioventus, down from $96.3 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $97.6 million in Q3 2023 to a low of $34.0 million in Q3 2021.
- Median Inventory over the past 5 years was $87.8 million (2023), compared with a mean of $78.8 million.
- Biggest five-year swings in Inventory: surged 111.84% in 2021 and later dropped 11.07% in 2025.
- Bioventus' Inventory stood at $61.7 million in 2021, then skyrocketed by 37.41% to $84.8 million in 2022, then grew by 7.75% to $91.3 million in 2023, then grew by 1.25% to $92.5 million in 2024, then dropped by 11.07% to $82.2 million in 2025.
- The last three reported values for Inventory were $82.2 million (Q4 2025), $96.3 million (Q3 2025), and $96.5 million (Q2 2025) per Business Quant data.